REFILE-UPDATE 1-FDA rejects wider use of Amag anemia drug; shares slide
Amag Pharmaceuticals Inc said the U.S. Food and Drug Administration rejected its application for wider use of its iron deficiency drug due to safety concerns and asked for more trial data.
No comments:
Post a Comment